The recent rise in colorectal cancer among individuals under 50 is a concerning trend that has left experts scratching their heads. The death of James Van Der Beek, a beloved actor known for his role in Dawson's Creek, at just 48 years old, has brought this issue into the spotlight. Van Der Beek's diagnosis and subsequent passing serve as a stark reminder that this cancer is no longer exclusive to older adults.
Colorectal cancer, also known as bowel cancer, has seen a significant increase in diagnoses among younger individuals since the 1990s. Helen Coleman, a cancer epidemiology professor at Queen's University Belfast, revealed to AFP that the rate of people under 50 being diagnosed with this cancer has risen by approximately a third. This trend is particularly alarming as it has made colorectal cancer the leading cause of cancer-related deaths among under-50s in the United States, according to research published in the JAMA journal.
While the increase may sound alarming, Coleman emphasizes that it has come from a relatively low starting point. The vast majority of cases still occur among older individuals, with only 6% of all colorectal cancers being diagnosed in people under 50, according to her research in Northern Ireland. Additionally, rates are stabilizing or even decreasing among older people in some areas due to improved screening methods.
However, the perception that colorectal cancer is an elderly person's disease can be detrimental. Younger individuals may not consider themselves at risk, leading to delayed diagnoses and poorer outcomes. As Van Der Beek's case demonstrates, by the time symptoms are recognized and a diagnosis is made, it may already be too late.
So, what is driving this increase in colorectal cancer among younger individuals? Similar to other cancers affecting young people, colorectal cancer has been linked to lifestyle factors such as being overweight, poor diet, lack of exercise, drinking, and smoking. However, these factors alone cannot fully explain the significant and rapid change in colorectal cancer rates.
Many of the younger patients, including Van Der Beek, appeared to be in good health prior to their diagnoses. In a December TV interview, Van Der Beek shared his surprise, stating, "I was biohacking, doing saunas, cold plunges, and all that—and I had stage three cancer and had no idea."
Researchers like Jenny Seligmann, a colorectal cancer specialist at the University of Leeds in the UK, admit that they don't have all the answers. "We don't know," Seligmann told AFP. This mystery has led experts to explore other potential causes, including the microbiome, a complex ecosystem of microbes in our guts that is still not fully understood.
A study published in the journal Nature last year provided a "really important first clue" in this area, according to Coleman. The study found that DNA mutations of a toxin called colibactin, produced by the common bacteria E.Coli, were much more common in younger people with colorectal cancer compared to older patients. However, more research is needed to understand this connection fully.
Additionally, there is evidence suggesting that repeated use of antibiotics could be associated with early-onset colorectal cancer. Seligmann also notes that she sees many different subtypes of colorectal cancer in her clinic, indicating that there is likely not a single cause behind this rise.
"It's going to be very difficult to pinpoint it to one cause," Seligmann said.
In light of this growing concern, the United States lowered the age for colorectal cancer screening from 50 to 45 in 2021. This decision was made to catch more cases early and improve outcomes. Other countries, such as the UK and France, which currently start screening at age 50, are facing calls to follow suit.
Before his death, Van Der Beek urged people to be vigilant and get tested if they experience any symptoms. He emphasized, "If you are 45 or older, talk to your doctor."
The most common symptom of colorectal cancer is changes in bowel movements, such as diarrhea or constipation. Other symptoms include blood in feces, unexplained weight loss, and fatigue.
This issue is a complex and evolving one, and further research is needed to fully understand the causes and develop effective prevention strategies. In the meantime, staying informed, being aware of symptoms, and considering screening options are crucial steps towards early detection and better outcomes.
